Filing Details

Accession Number:
0001493152-24-025831
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-01 17:00:27
Reporting Period:
2024-07-01
Accepted Time:
2024-07-01 17:00:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819411 Gain Therapeutics Inc. GANX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1313876 I Eric Richman C/O Gain Therapeutics, Inc.
4800 Montgomery Lane, Suite 220
Bethesda MD 20814
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-01 5,000 $1.23 277,629 No 4 P Direct
Common Stock Acquisiton 2024-07-01 12,000 $1.21 289,629 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,829 Indirect By Trust
Footnotes
  1. Shares are held by the Eric I. Richman Living Trust (the "Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of his proportionate pecuniary interest therein.